Article Information
History
- February 21, 2021.
Article Versions
- Version 1 (February 16, 2021 - 07:19).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- COVID-19 Pandemic UK-based Interest Group of Childhood Cancer and Diabetes,
- Gemma Williams15,
- Ross McLean11,
- Jo-Fen Liu7,
- Timothy Ritzmann7,6,
- Madhumita Dandapani7,6,
- Dhurgshaarna Shanmugavadivel7,
- Pooja Sachdev9,
- Mark Brougham2,
- Rod Mitchell12,1,
- Nicholas T Conway4,5,
- James Law9,
- Alice Cunnington6,
- Gbemi Ogunnaike14,
- Karen Brougham2,
- Elizabeth Bayman1 and
- David A Walker7,*
- 1Department of Paediatric Diabetes and Endocrinology, Royal Hospital for Sick Children, Edinburgh
- 2Department of Paediatric Oncology, Royal Hospital for Sick Children, Edinburgh
- 4Tayside Children’s Hospital, NHS Tayside
- 5Division of Population Health and Genomics, University of Dundee
- 6Nottingham University Hospitals NHS Trust, Nottingham, UK
- 7Children’s Brain Tumour Research Centre, University of Nottingham, Nottingham, UK
- 9Department of Paediatric Diabetes and Endocrinology, Nottingham University Hospitals NHS Trust
- 11University Hospital Wishaw, NHS Lanarkshire
- 12MRC Centre for Reproductive Health, The University of Edinburgh
- 14Nottingham University Hospitals NHS Trust
- 15Paediatric Oncology, Leeds Children’s Hospital, Leeds Teaching Hospital NHS Trust
- ↵*Corresponding author
: Professor David Walker, Children’s Brain Tumour Research Centre, University of Nottingham, Nottingham NG7 2UH, Email: david.walker{at}nottingham.ac.uk, Tel: (0115) 823 0629